NFKB1 and breast cancer: Exosomal miR-503 derived from tumour cells promotes M1-M2 conversion of microglia through manipulating STAT3 and NF-κB signalling pathways, followed by enhancing their PD-L1 expression to suppress local immunity and thereby promote brain metastases of breast cancer [25].